Pharmacology · Respiratory and GIT Pharmacology

Which property of formoterol, unlike salmeterol, allows it to be used both as maintenance therapy and as a reliever medication in single-inhaler combination regimens with budesonide?

  • A Longer duration of action than salmeterol
  • B Resistance to COMT metabolism
  • C Absence of beta-2 selectivity
  • D Rapid onset of bronchodilation comparable to salbutamol
Correct answer: D. Rapid onset of bronchodilation comparable to salbutamol

Explanation

Formoterol is a full beta-2 agonist with a lipophilicity profile that gives it both a rapid onset (within 1 to 3 minutes, similar to salbutamol) and a long duration of about 12 hours. This dual profile underpins MART or SMART regimens where the same budesonide-formoterol inhaler serves maintenance and relief. Salmeterol has a slower onset of 15 to 30 minutes due to its exosite binding, making it unsuitable for rescue use.

Reference: Katzung's Basic and Clinical Pharmacology, 16th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Respiratory and GIT Pharmacology MCQs

See all Respiratory and GIT Pharmacology MCQs →